Omoc-oc, Baby Boy .
HRN: 22-24-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/22/2022
11/29/2022
IVTT
45mg
Q24h
PSNB (MSAF)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes